Last updated on September 2018

Kineret CAPS Post Authorisation Study


Brief description of study

A non-interventional, post authorization safety study to evaluate the safety of Kineret in the treatment of Cryopyrin Associated Periodic Syndromes (CAPS) in routine clinical care with regard to serious infections, malignancies, injection site reactions, allergic reactions and medication errors, including re-use of syringe.

Clinical Study Identifier: NCT02326376

Contact Investigators or Research Sites near you

Start Over

Elisa Patrone

Swedish Orphan Biovitrum Investigational Site
Lille, France

Elisa Patrone

Swedish Orphan Biovitrum Investigational Site
Paris, France

Elisa Patrone

Swedish Orphan Biovitrum Investigational Site
Groningen, Netherlands

Elisa Patrone

Swedish Orphan Biovitrum Investigational Site
Utrecht, Netherlands

Elisa Patorne

Swedish Orphan Biovitrum Investigational Site
London, United Kingdom

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.